For research use only. Not for human or veterinary use. Supplied as a lyophilized powder for laboratory research.
Peptide purity grades such as “>95%”, “>98%” or “>99%” describe the chromatographic purity of a lot: the target peptide’s share of total detected peak area under a specific HPLC or UPLC method [1]. They do not describe how much of the powder’s weight is peptide, and they do not cover endotoxin, counter-ions or water [2][3]. Reading a purity grade correctly means checking the method, the specification and what the remaining percent might contain.
What a peptide purity percentage measures
- Basis: peak area of the main peak divided by total integrated peak area, at the detection wavelength used [1].
- Relative: components not detected by the method are not counted.
- Method-dependent: a different column, gradient or wavelength can give a different number for the same sample [1].
What the other 1–5% contains
Synthetic peptides have characteristic related impurities [4]:
- Deletion sequences (a missing amino acid) and insertion sequences (an extra one)
- Diastereomers from racemization during synthesis
- Incompletely removed protecting groups and side-chain adducts
- Oxidation products and degradation products such as diketopiperazine, pyroglutamate and succinimide forms
- Dimers and aggregates
Some of these are structurally very close to the target, which is why LC-MS characterization is used to identify them [1].
Specification vs result
A specification is the acceptance criterion set before testing; the result is what the lot measured. ICH quality guidance describes specifications as a list of tests, references to analytical procedures, and acceptance criteria [5]. On a certificate, look for both. Example: MFP’s BPC-157 lot DPS-9628420 shows “Specification >98% / Result 99.42%”, and TB-500 (Thymosin Beta-4) lot DPS-2022011 reports 99.38%.
Purity grade vs net peptide content
| Grade on COA | What it tells you | What it does not tell you |
|---|---|---|
| >95% HPLC | Main peak ≥95% of detected area | Weight fraction of peptide |
| >98% HPLC | Main peak ≥98% of detected area | Counter-ion (TFA) or water content |
| >99% HPLC | Main peak ≥99% of detected area | Endotoxin or sterility |
Mass-balance studies show the gap: a purified peptide reference material had a final purity of 691 mg/g after accounting for nearly 25% TFA by mass [2], and purified sublancin was 78.6% peptide by mass balance [3]. See Net Peptide Content.
Frequently asked questions
That the target peptide accounted for 99% of the detected peak area under the stated HPLC or UPLC method [1].
It means at most about 2% of detected peak area is related impurities. Whether that is sufficient depends on the experiment.
Mostly synthesis by-products (deletion and insertion sequences, diastereomers, protecting-group residues) and degradation products [4].
No. Those are measured separately and reduce net peptide content, not HPLC purity [2][3].
Research materials and certificates
References
- Lian Z, Wang N, Tian Y, Huang L. Characterization of Synthetic Peptide Therapeutics Using Liquid Chromatography-Mass Spectrometry: Challenges, Solutions, Pitfalls, and Future Perspectives. J Am Soc Mass Spectrom. 2021;32(8):1852-1860. doi:10.1021/jasms.0c00479. PMID: 34110145
- Melanson JE, Thibeault MP, Stocks BB, Leek DM, McRae G, Meija J. Purity assignment for peptide certified reference materials by combining qNMR and LC-MS/MS amino acid analysis results: application to angiotensin II. Anal Bioanal Chem. 2018;410(26):6719-6731. doi:10.1007/s00216-018-1272-7. PMID: 30143839
- Chen W, Yan J, Yang M, et al. SI-traceable purity assignment for peptide sublancin using mass balance approach and isotope dilution mass spectrometry based on amino acid analysis. J Chromatogr B Analyt Technol Biomed Life Sci. 2026;1277:125038. doi:10.1016/j.jchromb.2026.125038. PMID: 41916078
- D’Hondt M, Bracke N, Taevernier L, et al. Related impurities in peptide medicines. J Pharm Biomed Anal. 2014;101:2-30. doi:10.1016/j.jpba.2014.06.012. PMID: 25044089
- U.S. Food and Drug Administration. Q6B Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products (ICH guidance). fda.gov
Research-use-only disclaimer: All products from My Freedom Peptides are supplied as a lyophilized powder for laboratory research. They are for research use only and not for human or veterinary use. My Freedom Peptides LLC is a chemical supplier. It is not a 503A compounding pharmacy or a 503B outsourcing facility. These statements have not been evaluated by the Food and Drug Administration. Products are not intended to diagnose, treat, cure, or prevent any disease.
